Wheeler TM - Search Results

1

Reduced levels of transforming growth factor beta receptor type II in human prostate cancer: an immunohistochemical study.

Williams RH, Stapleton AM, Yang G, Truong LD, Rogers E, Timme TL, Wheeler TM, Scardino PT, Thompson TC. Williams RH, et al. Among authors: wheeler tm. Clin Cancer Res. 1996 Apr;2(4):635-40. Clin Cancer Res. 1996. PMID: 9816213

2

High levels of phosphorylated form of Akt-1 in prostate cancer and non-neoplastic prostate tissues are strong predictors of biochemical recurrence.

Ayala G, Thompson T, Yang G, Frolov A, Li R, Scardino P, Ohori M, Wheeler T, Harper W. Ayala G, et al. Clin Cancer Res. 2004 Oct 1;10(19):6572-8. doi: 10.1158/1078-0432.CCR-04-0477. Clin Cancer Res. 2004. PMID: 15475446

3

Elevated Skp2 protein expression in human prostate cancer: association with loss of the cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence-free survival.

Yang G, Ayala G, De Marzo A, Tian W, Frolov A, Wheeler TM, Thompson TC, Harper JW. Yang G, et al. Among authors: wheeler tm. Clin Cancer Res. 2002 Nov;8(11):3419-26. Clin Cancer Res. 2002. PMID: 12429629

4

The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with clinically localized prostate cancer.

Kattan MW, Shariat SF, Andrews B, Zhu K, Canto E, Matsumoto K, Muramoto M, Scardino PT, Ohori M, Wheeler TM, Slawin KM. Kattan MW, et al. Among authors: wheeler tm. J Clin Oncol. 2003 Oct 1;21(19):3573-9. doi: 10.1200/JCO.2003.12.037. Epub 2003 Aug 11. J Clin Oncol. 2003. PMID: 12913106 Clinical Trial.

5

Development of an immunoassay for serum caveolin-1: a novel biomarker for prostate cancer.

Tahir SA, Ren C, Timme TL, Gdor Y, Hoogeveen R, Morrisett JD, Frolov A, Ayala G, Wheeler TM, Thompson TC. Tahir SA, et al. Among authors: wheeler tm. Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3653-9. Clin Cancer Res. 2003. PMID: 14506154

6

Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer.

Ayala G, Tuxhorn JA, Wheeler TM, Frolov A, Scardino PT, Ohori M, Wheeler M, Spitler J, Rowley DR. Ayala G, et al. Among authors: wheeler tm, wheeler m. Clin Cancer Res. 2003 Oct 15;9(13):4792-801. Clin Cancer Res. 2003. PMID: 14581350

7

Reduced infiltration of class A scavenger receptor positive antigen-presenting cells is associated with prostate cancer progression.

Yang G, Addai J, Tian WH, Frolov A, Wheeler TM, Thompson TC. Yang G, et al. Among authors: wheeler tm. Cancer Res. 2004 Mar 15;64(6):2076-82. doi: 10.1158/0008-5472.can-03-4072. Cancer Res. 2004. PMID: 15026346

8

Combined c-Myc and caveolin-1 expression in human prostate carcinoma predicts prostate carcinoma progression.

Yang G, Timme TL, Frolov A, Wheeler TM, Thompson TC. Yang G, et al. Among authors: wheeler tm. Cancer. 2005 Mar 15;103(6):1186-94. doi: 10.1002/cncr.20905. Cancer. 2005. PMID: 15712208 Free article.

9

Stromal antiapoptotic paracrine loop in perineural invasion of prostatic carcinoma.

Ayala GE, Dai H, Tahir SA, Li R, Timme T, Ittmann M, Frolov A, Wheeler TM, Rowley D, Thompson TC. Ayala GE, et al. Among authors: wheeler tm. Cancer Res. 2006 May 15;66(10):5159-64. doi: 10.1158/0008-5472.CAN-05-1847. Cancer Res. 2006. PMID: 16707439

10

Forkhead protein FKHR and its phosphorylated form p-FKHR in human prostate cancer.

Li R, Erdamar S, Dai H, Wheeler TM, Frolov A, Scardino PT, Thompson TC, Ayala GE. Li R, et al. Among authors: wheeler tm. Hum Pathol. 2007 Oct;38(10):1501-7. doi: 10.1016/j.humpath.2007.02.016. Epub 2007 Jun 26. Hum Pathol. 2007. PMID: 17597184 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

330 results

Search Page

Filters